<DOC>
	<DOCNO>NCT01635062</DOCNO>
	<brief_summary>The purpose study evaluate whether vitamin D receptor agonist therapy lower renin-angiotensin system activity .</brief_summary>
	<brief_title>The VALIDATE-D Study</brief_title>
	<detailed_description>This study aim evaluate whether vitamin D receptor agonist therapy ( calcitriol ) diabetes lower renin-angiotensin system ( RAS ) activity manner similar ACE inhibitor . This physiology study , focus evaluate hormonal change circulate tissue RAS compare placebo . Subjects type 2 diabetes obesity normal kidney function undergo evaluation circulate renal-vascular RAS activity urinary protein baseline , withdraw interfere medication , control electrolyte diet , control posture setting . They randomly receive study medication ( calcitriol placebo ) 3 week follow re-assessment RAS parameter . The main outcome evaluate follow calcitriol/placebo include measure circulate RAS ( primary ) , well measure renal-vascular RAS , urine protein , adipocytokine level , adipose-tissue RAS activity ( secondary ) In extension phase , Lisinopril add study drug another 2 week follow another assessment primary secondary outcome parameter , subject continue lisinopril+study drug 3 additional month one final assessment RAS parameter urinary protein .</detailed_description>
	<mesh_term>Lisinopril</mesh_term>
	<mesh_term>Calcitriol</mesh_term>
	<criteria>1 . TypeTwo Diabetes ( treat diet alone , oral hypoglycemic agent , single injection basal insulin daily ) 2 . Normal blood pressure , Mild ( Stage 1 ) Hypertension either untreated , adequately treat single antihypertensive drug . 3 . Age &gt; 18 year &lt; 70 year 4 . Estimated GFR &gt; 60ml/min 5 . Normal laboratory value : Complete blood count , sodium , potassium , glucose , liver enzymes , urinalysis 6 . Electrocardiogram without sign prior infarction , ventricular conduction abnormality , supraventricular arrhythmia . 1 . Chronic Kidney Disease eGFR &lt; 60 2 . History nephrolithiasis ( kidney stone ) 3 . Multiple ( one ) insulin injection daily ( since insulin alter RAS ) 4 . Poorly control type 2 diabetes ( That may require aggressive therapy ) define HbA1c &gt; 8.5 % 5 . Type 1 diabetes 6 . Stage 2 Stage 3 hypertension use 1 antihypertensive drug 7 . Chronic inflammatory condition ( inflammatory bowel disease arthritis ) treat prescribed dos NSAIDs physician . 8 . The use prescribed dos potassium supplement . 9 . History liver failure 10 . History parathyroid granulomatous disorder 11 . History heart failure , cerebrovascular disease coronary heart disease 12 . History known microvascular complication diabetes ( include retinopathy , neuropathy , nephropathy ) 13 . Illness require overnight hospitalization past 6 month 14 . Active tobacco recreational drug use 15 . Pregnancy current breast feeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>